XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION (Tables)
 6 Months Ended
Apr. 30, 2017
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below:
 
Three Months Ended
 
Six Months Ended
 
April 30,
 
April 30,
 
2017
 
2016
 
2017
 
2016
 
(in millions)
Net Revenue:
 
 
 
 
 
 
 
Life Sciences and Applied Markets
$
523

 
$
495

 
$
1,063

 
$
1,021

Diagnostics and Genomics
201

 
178

 
365

 
336

Agilent CrossLab
378

 
346

 
741

 
690

Total net revenue
$
1,102

 
$
1,019

 
$
2,169

 
$
2,047

 
 
 
 
 
 
 
 
Segment Income From Operations:


 


 
 
 
 
Life Sciences and Applied Markets
$
110

 
$
94

 
$
236

 
$
208

Diagnostics and Genomics
49

 
27

 
72

 
42

Agilent CrossLab
82

 
74

 
156

 
150

Total segment income from operations
$
241

 
$
195

 
$
464

 
$
400

The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.  
 
April 30,
2017
 
October 31,
2016
 
(in millions)
Segment Assets:
 
 
 
Life Sciences and Applied Markets
$
1,658

 
$
1,687

Diagnostics and Genomics
2,066

 
1,960

Agilent CrossLab
1,117

 
1,082

Total segment assets
$
4,841

 
$
4,729
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments’ income from operations to Agilent’s total enterprise income before taxes: 
 
Three Months Ended
 
Six Months Ended
 
April 30,
 
April 30,
 
2017
 
2016
 
2017
 
2016
 
(in millions)
Total reportable segments’ income from operations
$
241

 
$
195

 
$
464

 
$
400

Transformational initiatives
—

 
(10
)
 
(2
)
 
(21
)
Amortization of intangibles
(31
)
 
(40
)
 
(62
)
 
(83
)
Acquisition and integration costs
(7
)
 
(12
)
 
(21
)
 
(17
)
Business exit and divestiture costs (primarily our NMR business)
—

 
(1
)
 
—

 
(6
)
Pension settlement gain
—

 
—

 
32

 
1

Pension curtailment gain
—

 
—

 
—

 
15

Other
(2
)
 
(1
)
 
(4
)
 
(3
)
Interest income
5

 
3

 
9

 
5

Interest expense
(20
)
 
(18
)
 
(40
)
 
(36
)
Other income (expense), net
5

 
1

 
8

 
4

Income before taxes, as reported
$
191

 
$
117

 
$
384

 
$
259